ConductScience.org, home

Paper7732003

T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein.

Stemme S and 5 others. Proc Natl Acad Sci U S A, 1995. Cited by 761 papers, by iCite.

Cite this record

ConductScience Library. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Papers, record 7732003. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7732003

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein.
PubMed
Journal
Proc Natl Acad Sci U S A
PubMed
Year
1995
PubMed
Publication types
Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
761
iCite
Relative citation ratio, by iCite
16.7
iCite
Revised in PubMed
2022-03-10
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Stemme SS
2Faber BB
3Holm JJ
4Wiklund OO
5Witztum JLJ L
6Hansson GKG K

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ArteriosclerosisMajor topic
CD4-Positive T-LymphocytesMajor topic
Lipoproteins, LDLMajor topic
Lymphocyte ActivationMajor topic
T-LymphocytesMajor topic
Antibodies, Monoclonal
Antigen-Presenting Cells
Antigens, CD
Clone Cells
Cytokines
HLA-D Antigens
HLA-DR Antigens
Humans
Immunophenotyping
Interleukin-4
Monocytes

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
14197PHS HHSUnited StatesPubMed

Source PubMed

Download CSV of grants

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT00863967Early Detection of ArteriosclerosisBackground

Source ClinicalTrials.gov

Download CSV of trials

References47

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12509626Interferon gamma inhibits both proliferation and expression of differentiation-specific alpha-smooth muscle actin in arterial smooth muscle cells.J Exp Med1989https://conductscience.org/library/papers/2509626PubMed
22794046Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man.J Clin Invest1989https://conductscience.org/library/papers/2794046PubMed
32307933Naive and memory T cells show distinct pathways of lymphocyte recirculation.J Exp Med1990https://conductscience.org/library/papers/2307933PubMed
41693068Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein.Arteriosclerosis1990https://conductscience.org/library/papers/1693068PubMed
51693069Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits.Arteriosclerosis1990https://conductscience.org/library/papers/1693069PubMed
62114402Inhibition of mouse macrophage degradation of acetyl-low density lipoprotein by interferon-gamma.J Biol Chem1990https://conductscience.org/library/papers/2114402PubMed
71898663Differentiation of T cell lymphokine gene expression: the in vitro acquisition of T cell memory.J Exp Med1991https://conductscience.org/library/papers/1898663PubMed
81990208Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions.Lab Invest1991https://conductscience.org/library/papers/1990208PubMed
91990440Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis.Science1991https://conductscience.org/library/papers/1990440PubMed
101816326Modification of copper-catalyzed oxidation of low density lipoprotein by proteoglycans and glycosaminoglycans.J Lipid Res1991https://conductscience.org/library/papers/1816326PubMed
111394884Interferon-gamma and tumor necrosis factor synergize to induce nitric oxide production and inhibit mitochondrial respiration in vascular smooth muscle cells.Circ Res1992https://conductscience.org/library/papers/1394884PubMed
128427763Immune and inflammatory mechanisms in the development of atherosclerosis.Br Heart J1993https://conductscience.org/library/papers/8427763PubMed
138479518The pathogenesis of atherosclerosis: a perspective for the 1990s.Nature1993https://conductscience.org/library/papers/8479518PubMed
148349785Oxidatively modified low density lipoprotein is a chemoattractant for human T lymphocytes.J Clin Invest1993https://conductscience.org/library/papers/8349785PubMed
157506053Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL.Arterioscler Thromb1994https://conductscience.org/library/papers/7506053PubMed
167511933ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis. Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum.Arterioscler Thromb1994https://conductscience.org/library/papers/7511933PubMed
182012178Synthesis of IL-1 alpha and IL-1 beta by arterial cells in atherosclerosis.Am J Pathol1991https://conductscience.org/library/papers/2012178PubMed
191911708Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells.Arterioscler Thromb1991https://conductscience.org/library/papers/1911708PubMed
201836515Polyclonal origin of T lymphocytes in human atherosclerotic plaques.Lab Invest1991https://conductscience.org/library/papers/1836515PubMed
211531930T lymphocytes in human atherosclerotic plaques are memory cells expressing CD45RO and the integrin VLA-1.Arterioscler Thromb1992https://conductscience.org/library/papers/1531930PubMed

See all 47 referencesDownload CSV of references

Cited by295

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 761 citations.

PMIDTitleJournalYearIn PapersSource
42861311Routine Blood Biomarkers and CD4⁺ T-Cell States in Atherosclerosis: A Narrative Review and Conceptual Framework.Int J Gen Med2026https://conductscience.org/library/papers/42861311PubMed
42787603ApoB-specific CD4+ T cells in atherosclerosis: MHC-II antigen presentation, T cell plasticity, and immune tolerance.Front Immunol2026https://conductscience.org/library/papers/42787603PubMed
42694900Targeting Inflammation in Atherosclerosis: Mechanistic Rationale, Clinical Trials, and Regulatory Considerations.Rev Cardiovasc Med2026https://conductscience.org/library/papers/42694900PubMed
42540283Molybdenum Nanoparticles Alleviate Psoriasis-Related Cardiovascular Oxidative Stress and Inflammation.ACS Omega2026https://conductscience.org/library/papers/42540283PubMed
42001296T Cell Receptor Repertoires Across the Continuum of Vascular, Myocardial, and Age-Related Diseases.Immunol Rev2026https://conductscience.org/library/papers/42001296PubMed
41660200Relationships Between Circulating Lipids, Lipoproteins, and Lymphocyte Subsets in the Multi-Ethnic Study of Atherosclerosis.Glob Heart2026https://conductscience.org/library/papers/41660200PubMed
41057609Progenitor exhausted PD-1+ T cells are cellular targets of immune checkpoint inhibition in atherosclerosis.Nat Cardiovasc Res2025https://conductscience.org/library/papers/41057609PubMed
40823653Mitigating atherosclerosis: Integrating vaccines with gene targets.Am Heart J Plus2025https://conductscience.org/library/papers/40823653PubMed
40552286Atherosclerosis: from lipid-lowering and anti-inflammatory therapies to targeting arterial retention of ApoB-containing lipoproteins.Front Immunol2025https://conductscience.org/library/papers/40552286PubMed
40533521Loss of effector Treg signature in APOB-reactive CD4+ T cells in patients with coronary artery disease.Nat Cardiovasc Res2025https://conductscience.org/library/papers/40533521PubMed
40472288Adult thymectomy is associated with increased mortality risk from cancer but not cardiovascular disease.Blood Adv2025https://conductscience.org/library/papers/40472288PubMed
40454002Mechanisms and implications of vascular-homing CD8 T cells in atherosclerosis.NPJ Cardiovasc Health2025https://conductscience.org/library/papers/40454002PubMed
40397286Wogonin Attenuates Atherosclerosis via KLF11-Mediated Suppression of PPARα-YAP1-Driven Glycolysis and Enhancement of ABCA1/G1-Mediated Cholesterol Efflux.Adv Sci (Weinh)2025https://conductscience.org/library/papers/40397286PubMed
40356915ICI-induced cardiovascular toxicity: mechanisms and immune reprogramming therapeutic strategies.Front Immunol2025https://conductscience.org/library/papers/40356915PubMed
40027512Analysis and validation of biomarkers and immune cell infiltration profiles in unstable coronary atherosclerotic plaques using bioinformatics and machine learning.Front Cardiovasc Med2025https://conductscience.org/library/papers/40027512PubMed
39769058Unravelling the Mechanisms of Oxidised Low-Density Lipoprotein in Cardiovascular Health: Current Evidence from In Vitro and In Vivo Studies.Int J Mol Sci2024https://conductscience.org/library/papers/39769058PubMed
39691830Enhanced levels of IL-6 and PAI-1 and decreased levels of MMP-3 in cytomegalovirus seropositive patients with prior myocardial infarction.Int J Cardiol Heart Vasc2025https://conductscience.org/library/papers/39691830PubMed
39473192Legumain deficiency halts atherogenesis by modulating T cell receptor signaling.Aging Cell2025https://conductscience.org/library/papers/39473192PubMed
39404934Targeting Inflammatory Pathways in Atherosclerosis: Exploring New Opportunities for Treatment.Curr Atheroscler Rep2024https://conductscience.org/library/papers/39404934PubMed
39196001Understanding autoimmunity in atherosclerosis paves the way for novel therapies.Nat Cardiovasc Res2023https://conductscience.org/library/papers/39196001PubMed

See all 295 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
IFNG3458PubTator's text mininghttps://conductscience.org/library/genes/3458NCBI Gene
IL43565PubTator's text mininghttps://conductscience.org/library/genes/3565NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7732003

GET https://conductscience.org/api/papers/v1/7732003/references?page=2